🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
COSCIENS Biopharma Inc. (TSX:CSCI)
Canada flag Canada · Delayed Price · Currency is CAD
8.25
-0.35 (-4.07%)
Nov 19, 2026, 11:10 AM EST

COSCIENS Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
4.93-10.36-15.31-3.493.45-8.37
Depreciation & Amortization
1.271.191.611.441.470.15
Loss (Gain) From Sale of Assets
-11.26-----0
Asset Writedown & Restructuring Costs
2.040.244.26---
Stock-Based Compensation
0.24-0.010.460.190.070.31
Other Operating Activities
0.060.18-3.07-0.791.18-3.17
Change in Accounts Receivable
-1.061.15-1.681.86-0.610.12
Change in Inventory
0.471.421.11-1.16-1.09-0.06
Change in Accounts Payable
0.43-2.45-0.82-0.420.810.63
Change in Unearned Revenue
0.010.010.22--3.01
Change in Income Taxes
------0.11
Change in Other Net Operating Assets
1.350.17-0.59-0.130.02-1.1
Operating Cash Flow
-1.51-8.47-14.57-2.585.23-8.58
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.16-0.71-1.16-0.72-0.3-0.03
Sale of Property, Plant & Equipment
0.250.24---0
Cash Acquisitions
-7.63-26.04---
Sale (Purchase) of Intangibles
------0.61
Other Investing Activities
-0.200.21-0.01--0.02
Investing Cash Flow
-7.77-0.4625.08-0.73-0.3-0.66

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.37-0.42-0.37-0.33-0.13
Lease Payments
-0.21-0.37-0.42-0.37-0.33-0.13
Net Debt Issued (Repaid)
10.37-0.37-0.42-0.37-0.33-0.13
Issuance of Common Stock
---0.010.0654.29
Other Financing Activities
--0.04-0.17---3.12
Financing Cash Flow
10.06-0.41-0.59-0.36-0.2751.04

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.10.25-0.210.16-0.63-0.77
Net Cash Flow
0.68-9.099.72-3.514.0341.03

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1.67-9.18-15.73-3.34.93-8.61
Free Cash Flow Growth
------
Free Cash Flow Margin
-17.14%-122.42%-164.07%-46.26%33.80%-163.71%
Free Cash Flow Per Share
-1.40-8.70-18.28-5.377.97-22.48
Levered Free Cash Flow
5.1-6.32-2.44-7.73.78-4.75
Unlevered Free Cash Flow
5.25-6.21-2.36-7.613.87-4.75
Free Cash Flow After Leases
-1.88-9.54-16.15-3.674.6-8.74

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
-----1.61
Change in Working Capital
1.20.29-2.510.06-0.942.5